Veerhealth Care Reports 112.40% YoY Growth in Q1 FY26, Secures USFDA Clearance

Veerhealth Care Limited, a leading small-cap company in India's Food & Drug (OTC) segment, has reported a robust 112.40% year-over-year growth in total income in Q1 FY26. The company's total income stood at ₹ 5.14 Crore. The company also reported an EBITDA of ₹ 0.62 Crore, representing a 82.35% YoY growth, and a net profit of ₹ 0.24 Crore, representing a 104.08% YoY growth. The company has received USFDA clearance, enabling exports of Drug (OTC) products to the USA and unlocking access to other international markets. Veerhealth Care is now eligible for larger export orders and is in the league of larger players in the segment. The company is also working towards scaling its manufacturing and export operations for products under the medical device category in the U.S. market.